Skip to main content
Top
Published in: Immunologic Research 2-3/2014

01-12-2014 | FRONTIERS IN AUTOIMMUNITY

A sudden onset of a pseudo-neurological syndrome after HPV-16/18 AS04-adjuvated vaccine: might it be an autoimmune/inflammatory syndrome induced by adjuvants (ASIA) presenting as a somatoform disorder?

Authors: Dimitri Poddighe, Lucia Castelli, Gian Luigi Marseglia, Paola Bruni

Published in: Immunologic Research | Issue 2-3/2014

Login to get access

Abstract

In last centuries, vaccines reduced the incidence of several infectious diseases. In last decades, some vaccines aimed at preventing also some cancers, where viruses play a causative role. However, several adverse events have been described after vaccines, but a causal relationship has been established only in a minority of cases. Here, we describe a pseudo-neurological syndrome occurred shortly after the administration of the bivalent HPV vaccine. Some autoimmune disorders, including neurological demyelinating diseases, have been reported after HPV vaccines, but the patient showed no organic lesions. The patient was diagnosed as having a functional somatoform syndrome, which was supposed to be autoimmune/inflammatory syndrome induced by adjuvants (ASIA), seen the temporal link with vaccination and the presence of anti-phospholipid autoantibodies. Immunological mechanisms of vaccines—and of adjuvants—have not been completely elucidated yet, and although there is no evidence of statistical association with many post-vaccination events, a causal link with vaccine cannot be excluded in some individuals.
Literature
1.
go back to reference Siegrist CA. Vaccine immunology. In: Vaccines. 6th ed. Philadelphia: Elsevier Press; 2013. p. 14–32. Siegrist CA. Vaccine immunology. In: Vaccines. 6th ed. Philadelphia: Elsevier Press; 2013. p. 14–32.
2.
go back to reference Ada G. Overview of vaccines. In: Vaccine protocols. 2nd ed. Totowa, NJ: Humana Press; 2003. p. 1–18. Ada G. Overview of vaccines. In: Vaccine protocols. 2nd ed. Totowa, NJ: Humana Press; 2003. p. 1–18.
3.
go back to reference Edelman R. An overview of adjuvant use. In: Vaccine adjuvants: preparation methods and research protocols. 1st ed. Totowa, NJ: Humana Press; 2000. p. 1–27. Edelman R. An overview of adjuvant use. In: Vaccine adjuvants: preparation methods and research protocols. 1st ed. Totowa, NJ: Humana Press; 2000. p. 1–27.
5.
go back to reference Kuroda E, Coban C, Ishii KJ. Particulate adjuvants and innate immunity: past achievements, present findings and future prospects. Int Rev Immunol. 2013;32:209–20.PubMedCentralCrossRefPubMed Kuroda E, Coban C, Ishii KJ. Particulate adjuvants and innate immunity: past achievements, present findings and future prospects. Int Rev Immunol. 2013;32:209–20.PubMedCentralCrossRefPubMed
6.
go back to reference Schiller JT, Lowy DR. Virus infections and human cancer: an overview. Recent Results Cancer Res. 2014;193:1–10.CrossRefPubMed Schiller JT, Lowy DR. Virus infections and human cancer: an overview. Recent Results Cancer Res. 2014;193:1–10.CrossRefPubMed
7.
go back to reference Malik H, Khan FH, Ahsan H. Human papillomavirus: current status and issues of vaccination. Arch Virol. 2014;159:199–205.CrossRefPubMed Malik H, Khan FH, Ahsan H. Human papillomavirus: current status and issues of vaccination. Arch Virol. 2014;159:199–205.CrossRefPubMed
8.
go back to reference Schiller JT, Lowy DR, Markowitz LE. Vaccine immunology. In: Vaccines. 6th ed. Philadelphia: Elsevier Press; 2013. p. 235–56. Schiller JT, Lowy DR, Markowitz LE. Vaccine immunology. In: Vaccines. 6th ed. Philadelphia: Elsevier Press; 2013. p. 235–56.
9.
go back to reference Ulrich JT. MPL® Immunostimulant: adjuvant formulations. In: Vaccine adjuvants: preparation methods and research protocols. London: Humana Press; 2000. p. 273–82. Ulrich JT. MPL® Immunostimulant: adjuvant formulations. In: Vaccine adjuvants: preparation methods and research protocols. London: Humana Press; 2000. p. 273–82.
10.
go back to reference Hutchinson DJ, Klein KC. Human Papillomavirus disease and vaccines. Am J Health Syst Pharm. 2008;65:2105–12.CrossRefPubMed Hutchinson DJ, Klein KC. Human Papillomavirus disease and vaccines. Am J Health Syst Pharm. 2008;65:2105–12.CrossRefPubMed
11.
go back to reference Gatto M, Agmon-Levin N, Soriano A, et al. Human papillomavirus vaccine and systemic lupus erythematosus. Clin Rheumatol. 2013;32:1301–7.CrossRefPubMed Gatto M, Agmon-Levin N, Soriano A, et al. Human papillomavirus vaccine and systemic lupus erythematosus. Clin Rheumatol. 2013;32:1301–7.CrossRefPubMed
12.
go back to reference Committee to Review Adverse Effects of Vaccines, Institute of Medicine of the National Academies. Human papilloma vaccine. In: Adverse effects of vaccine, evidence and causality. Washington, DC: National Academy Press; 2012. p. 505–24. Committee to Review Adverse Effects of Vaccines, Institute of Medicine of the National Academies. Human papilloma vaccine. In: Adverse effects of vaccine, evidence and causality. Washington, DC: National Academy Press; 2012. p. 505–24.
13.
go back to reference Plotkin SL, Plotkin SA. A short history of vaccination. In: Vaccines. 6th ed. Philadelphia: Elsevier Press; 2013. p. 1–13. Plotkin SL, Plotkin SA. A short history of vaccination. In: Vaccines. 6th ed. Philadelphia: Elsevier Press; 2013. p. 1–13.
14.
go back to reference Offit PA, De Stefano F. Vaccine safety. In: Vaccines. 6th ed. Elsevier Press, 2013. p. 1464–1480. Offit PA, De Stefano F. Vaccine safety. In: Vaccines. 6th ed. Elsevier Press, 2013. p. 1464–1480.
16.
go back to reference Galli L, Ballotti S. Gli eventi avversi, le precauzioni, le controindicazioni. In: Le vaccinazioni per la pratica pediatrica. Pisa: Pacini editore; 2006. p. 89–99. Galli L, Ballotti S. Gli eventi avversi, le precauzioni, le controindicazioni. In: Le vaccinazioni per la pratica pediatrica. Pisa: Pacini editore; 2006. p. 89–99.
17.
go back to reference Chen RT. Vaccine risks: real, perceived and unknown. Vaccine. 1999;17:41–6.CrossRef Chen RT. Vaccine risks: real, perceived and unknown. Vaccine. 1999;17:41–6.CrossRef
18.
go back to reference Balofsky A, Agmon-Levin N, Shoenfeld Y. The new H1N1 and HPV vaccines and old fears. Curr Opin Rheumatol. 2010;22:431–6.CrossRefPubMed Balofsky A, Agmon-Levin N, Shoenfeld Y. The new H1N1 and HPV vaccines and old fears. Curr Opin Rheumatol. 2010;22:431–6.CrossRefPubMed
19.
go back to reference Pollard KM. Introduction. In: Autoantibodies and autoimmunity: molecular mechanisms in health and disease. Weinheim: Wiley Press; 2006. p. 1–26. Pollard KM. Introduction. In: Autoantibodies and autoimmunity: molecular mechanisms in health and disease. Weinheim: Wiley Press; 2006. p. 1–26.
20.
go back to reference Amital H, Shoenfeld Y. Natural autoantibodies, heralding, protecting and inducing autoimmunity. In: Autoantibodies. 2nd ed. Philadelphia: Elsevier Press; 2007. p. 7–12. Amital H, Shoenfeld Y. Natural autoantibodies, heralding, protecting and inducing autoimmunity. In: Autoantibodies. 2nd ed. Philadelphia: Elsevier Press; 2007. p. 7–12.
21.
go back to reference Shoenfeld Y, Aharon-Maor A, Sherer Y. Vaccination as an additional player in the mosaic of autoimmunity. Clin Exp Rheumatol. 2000;18:181–4.PubMed Shoenfeld Y, Aharon-Maor A, Sherer Y. Vaccination as an additional player in the mosaic of autoimmunity. Clin Exp Rheumatol. 2000;18:181–4.PubMed
22.
go back to reference Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: what is the evidence. Lancet. 2003;362:1659–66.CrossRefPubMed Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: what is the evidence. Lancet. 2003;362:1659–66.CrossRefPubMed
23.
go back to reference Salemi S, D’Amelio R. Could autoimmunity be induced by vaccination? Int Rev Immunol. 2010;29:247–69.CrossRefPubMed Salemi S, D’Amelio R. Could autoimmunity be induced by vaccination? Int Rev Immunol. 2010;29:247–69.CrossRefPubMed
24.
go back to reference Soldevilla HF, Briones SFR, Navarra SV. Systemic lupus erythematosus following HPV immunization or infection? Lupus. 2012;21:158–61.CrossRefPubMed Soldevilla HF, Briones SFR, Navarra SV. Systemic lupus erythematosus following HPV immunization or infection? Lupus. 2012;21:158–61.CrossRefPubMed
25.
go back to reference Grimanldi-Bensouda L, Guillemot D, Godeau B, et al. Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects. J Intern Med. 2013;275:398–408.CrossRef Grimanldi-Bensouda L, Guillemot D, Godeau B, et al. Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects. J Intern Med. 2013;275:398–408.CrossRef
26.
go back to reference Goncalves AK, Cobucci RN, Rodrigues HM, Gosson de Melo A, Giraldo PC. Safety, tolerability and side effects of human papillomavirus vaccines: a systematic quantitative review. Braz J Infect Dis. 2014; Epub ahead of print. Goncalves AK, Cobucci RN, Rodrigues HM, Gosson de Melo A, Giraldo PC. Safety, tolerability and side effects of human papillomavirus vaccines: a systematic quantitative review. Braz J Infect Dis. 2014; Epub ahead of print.
27.
go back to reference Pellegrino P, Carnovale V, Pozzi M, et al. On the relationship between human papilloma virus vaccine and autoimmune diseases. Autoimmun Rev. 2014;13:736–41.CrossRefPubMed Pellegrino P, Carnovale V, Pozzi M, et al. On the relationship between human papilloma virus vaccine and autoimmune diseases. Autoimmun Rev. 2014;13:736–41.CrossRefPubMed
28.
go back to reference Karussis D, Petrou P. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmun Rev. 2014;13:215–24.CrossRefPubMed Karussis D, Petrou P. The spectrum of post-vaccination inflammatory CNS demyelinating syndromes. Autoimmun Rev. 2014;13:215–24.CrossRefPubMed
29.
30.
go back to reference Cervera R, Piette JC, Font J, et al. Anti-phospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum. 2002;46:1019–27.CrossRefPubMed Cervera R, Piette JC, Font J, et al. Anti-phospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum. 2002;46:1019–27.CrossRefPubMed
32.
go back to reference Voigt K, Nagel A, Meyer B, Langs G, Braukhaus C, Lowe B. Towards positive diagnostic criteria: a systematic review of somatoform disorder diagnoses and suggestions for future classification. J Psycosom Res. 2010;68:403–14.CrossRef Voigt K, Nagel A, Meyer B, Langs G, Braukhaus C, Lowe B. Towards positive diagnostic criteria: a systematic review of somatoform disorder diagnoses and suggestions for future classification. J Psycosom Res. 2010;68:403–14.CrossRef
33.
go back to reference Masuko K, Nakamura H. Functional somatic syndrome: how it could be relevant to rheumatologist. Mod Rheumatol. 2007;17:179–84.CrossRefPubMed Masuko K, Nakamura H. Functional somatic syndrome: how it could be relevant to rheumatologist. Mod Rheumatol. 2007;17:179–84.CrossRefPubMed
34.
go back to reference Kanaan RA, Lepine JP, Wessley SC. The association or otherwise of the functional somatic syndromes. Psycosom Med. 2007;69:855–9.CrossRef Kanaan RA, Lepine JP, Wessley SC. The association or otherwise of the functional somatic syndromes. Psycosom Med. 2007;69:855–9.CrossRef
35.
go back to reference Hausteiner-Wiehle C, Henningsen P. Irritable bowel syndrome: relations with functional, mental and somatoform disorders. World J Gastroenterol. 2014;20:6024–30.PubMedCentralCrossRefPubMed Hausteiner-Wiehle C, Henningsen P. Irritable bowel syndrome: relations with functional, mental and somatoform disorders. World J Gastroenterol. 2014;20:6024–30.PubMedCentralCrossRefPubMed
36.
go back to reference Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety and depression: a meta-analytic review. Psycosom Med. 2003;65:528–33.CrossRef Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety and depression: a meta-analytic review. Psycosom Med. 2003;65:528–33.CrossRef
37.
go back to reference Anderson G, Berk M, Maes M. Biological phenotypes underpin the physio-somatic symptoms of somatization, depression and chronic fatigue syndrome. Acta Psychiatr Scand. 2014;129:83–97.CrossRefPubMed Anderson G, Berk M, Maes M. Biological phenotypes underpin the physio-somatic symptoms of somatization, depression and chronic fatigue syndrome. Acta Psychiatr Scand. 2014;129:83–97.CrossRefPubMed
38.
go back to reference Theoharides TC, Papaliodis D, Konstantinidou A, Kempuraj D, Clemens A. Chronic fatigue syndrome, mast cells and tricyclic antidepressants. J Clin Psychopharmacol. 2005;25(6):515–20.CrossRefPubMed Theoharides TC, Papaliodis D, Konstantinidou A, Kempuraj D, Clemens A. Chronic fatigue syndrome, mast cells and tricyclic antidepressants. J Clin Psychopharmacol. 2005;25(6):515–20.CrossRefPubMed
39.
go back to reference Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121:953–9.CrossRefPubMed Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121:953–9.CrossRefPubMed
40.
go back to reference Rosemblum H, Shoenfeld Y, Amital H. The common immunogenic etiology of chronic fatigue syndrome: from infections to vaccines via adjuvants to ASIA syndrome. Infect Dis Clin N Am. 2011;25:851–63.CrossRef Rosemblum H, Shoenfeld Y, Amital H. The common immunogenic etiology of chronic fatigue syndrome: from infections to vaccines via adjuvants to ASIA syndrome. Infect Dis Clin N Am. 2011;25:851–63.CrossRef
41.
go back to reference Shoenfeld Y, Agmon-Levin N. ASIA: autoimmune/inflammatory syndrome induced by adjuvants. J Autoimm. 2011;36:4–8.CrossRef Shoenfeld Y, Agmon-Levin N. ASIA: autoimmune/inflammatory syndrome induced by adjuvants. J Autoimm. 2011;36:4–8.CrossRef
42.
go back to reference Vera-Lastra O, Medina G, Cruz-Dominguez M, Jara LJ, Shoenfeld Y. Expert Rev Clin Immunol. 2013;9(4):361–73.CrossRefPubMed Vera-Lastra O, Medina G, Cruz-Dominguez M, Jara LJ, Shoenfeld Y. Expert Rev Clin Immunol. 2013;9(4):361–73.CrossRefPubMed
43.
go back to reference Steele L, Sastre A, Gorkovich MM, Cook MR. Complex factors in the etiology of Gulf War Syndrome: wartime exposures and risk factors in veteran subgroups. Environ Health Perspect. 2012;120(1):112–8.PubMedCentralCrossRefPubMed Steele L, Sastre A, Gorkovich MM, Cook MR. Complex factors in the etiology of Gulf War Syndrome: wartime exposures and risk factors in veteran subgroups. Environ Health Perspect. 2012;120(1):112–8.PubMedCentralCrossRefPubMed
44.
go back to reference Zafrir Y, Agmon-Levin N, Shilton T, Shoenfeld Y. Autoimmunity following hepatitis B vaccine as part of the spectrum of Autoimmune(Auto-inflammatory) Syndrome Induced by Adjuvants (ASIA): analysis of 93 cases. Lupus. 2012;21:146–52.CrossRefPubMed Zafrir Y, Agmon-Levin N, Shilton T, Shoenfeld Y. Autoimmunity following hepatitis B vaccine as part of the spectrum of Autoimmune(Auto-inflammatory) Syndrome Induced by Adjuvants (ASIA): analysis of 93 cases. Lupus. 2012;21:146–52.CrossRefPubMed
45.
go back to reference Israeli E. Gulf War Syndrome as a part of the autoimmune (autoinflammatory) syndrome induced by adjuvants (ASIA). Lupus. 2012;21:190–4.CrossRefPubMed Israeli E. Gulf War Syndrome as a part of the autoimmune (autoinflammatory) syndrome induced by adjuvants (ASIA). Lupus. 2012;21:190–4.CrossRefPubMed
46.
go back to reference Hajdu SD, Agmon-Levin N, Shoenfeld Y. Silicone and autoimmunity. Eur J Clin Invest. 2011;41(2):203–11.CrossRefPubMed Hajdu SD, Agmon-Levin N, Shoenfeld Y. Silicone and autoimmunity. Eur J Clin Invest. 2011;41(2):203–11.CrossRefPubMed
47.
go back to reference Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Macrophagic Myofasciitis a vaccine(alum) autoimmune-related disease. Clin Rev Allerg Immunol. 2011;41:163–8.CrossRef Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Macrophagic Myofasciitis a vaccine(alum) autoimmune-related disease. Clin Rev Allerg Immunol. 2011;41:163–8.CrossRef
48.
go back to reference Gherardi RK, Authier FJ. Aluminum inclusion macrophagic myofaciitis: a recently identified condition. Immunol Allergy Clin. 2003;23:699–712.CrossRef Gherardi RK, Authier FJ. Aluminum inclusion macrophagic myofaciitis: a recently identified condition. Immunol Allergy Clin. 2003;23:699–712.CrossRef
49.
go back to reference Yj Tsai, Gershwin ME. The sick building syndrome: what is it when it is? Compr Ther. 2002;28:140–4.CrossRef Yj Tsai, Gershwin ME. The sick building syndrome: what is it when it is? Compr Ther. 2002;28:140–4.CrossRef
50.
go back to reference Martinez-Orozco FJ, Vicario JL, Villalibre-Valderrey I, De Andres C, Fernandez-Arquero M, Peraita-Adrados R. Narcolepsy with cataplexy and comorbid immunopathological diseases. J Sleep Res. 2014; Epub ahead of print. Martinez-Orozco FJ, Vicario JL, Villalibre-Valderrey I, De Andres C, Fernandez-Arquero M, Peraita-Adrados R. Narcolepsy with cataplexy and comorbid immunopathological diseases. J Sleep Res. 2014; Epub ahead of print.
51.
go back to reference Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y. Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects. J Autoimm. 2013;47:1–16.CrossRef Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y. Autoimmune/autoinflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects. J Autoimm. 2013;47:1–16.CrossRef
52.
go back to reference Blank M, Israeli E, Shoenfeld Y. When APS (Hughes syndrome) met the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Lupus. 2012;21:711–4.CrossRefPubMed Blank M, Israeli E, Shoenfeld Y. When APS (Hughes syndrome) met the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Lupus. 2012;21:711–4.CrossRefPubMed
53.
go back to reference Katzav A, Kivity S, Blank M, Shoenfeld Y, Chapman J. Adjuvant immunization induces high levels of pathogenic antiphospholipid antibodies in genetically prone mice: another facet of the ASIA syndrome. Lupus. 2012;21:210–6.CrossRefPubMed Katzav A, Kivity S, Blank M, Shoenfeld Y, Chapman J. Adjuvant immunization induces high levels of pathogenic antiphospholipid antibodies in genetically prone mice: another facet of the ASIA syndrome. Lupus. 2012;21:210–6.CrossRefPubMed
54.
go back to reference Cruz-Tapias P, Agmon-Levin N, Israeli E, Anaya JM, Shoenfeld Y. Autoimmune (auto-inflammatory) Syndrome Induced by Adjuvants (ASIA): animal models as proof of concept. Curr Med Chem. 2013;20(32):4030–6.CrossRefPubMed Cruz-Tapias P, Agmon-Levin N, Israeli E, Anaya JM, Shoenfeld Y. Autoimmune (auto-inflammatory) Syndrome Induced by Adjuvants (ASIA): animal models as proof of concept. Curr Med Chem. 2013;20(32):4030–6.CrossRefPubMed
55.
go back to reference Schwarz TF, Huang LM, Medina DM, et al. Four-year follow-up of the immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine when administered to adolescent girls aged 10–14 years. J Adol Health. 2012;50:187–94.CrossRef Schwarz TF, Huang LM, Medina DM, et al. Four-year follow-up of the immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine when administered to adolescent girls aged 10–14 years. J Adol Health. 2012;50:187–94.CrossRef
56.
57.
go back to reference Leslie DL, Kozma L, Martina A, et al. Neuropsychiatric disorders associated with streptococcal infection: a case-control study among privately insured children. J Am Acad Child Adolesc Psychiatry. 2008;47(10):1166–72.PubMedCentralCrossRefPubMed Leslie DL, Kozma L, Martina A, et al. Neuropsychiatric disorders associated with streptococcal infection: a case-control study among privately insured children. J Am Acad Child Adolesc Psychiatry. 2008;47(10):1166–72.PubMedCentralCrossRefPubMed
58.
go back to reference Hornig M. The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness. Curr Opin Rheumatol. 2013;25(4):488–95.CrossRefPubMed Hornig M. The role of microbes and autoimmunity in the pathogenesis of neuropsychiatric illness. Curr Opin Rheumatol. 2013;25(4):488–95.CrossRefPubMed
59.
go back to reference Buehler MR. A proposed mechanism for autism: an aberrant neurimmune response manifested as a psychiatric disorder. Med Hypoth. 2011;76:863–70.CrossRef Buehler MR. A proposed mechanism for autism: an aberrant neurimmune response manifested as a psychiatric disorder. Med Hypoth. 2011;76:863–70.CrossRef
60.
go back to reference Kim SE, Chang L. Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? Neurogastroenterol Motil. 2012;24:895–913.CrossRefPubMed Kim SE, Chang L. Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? Neurogastroenterol Motil. 2012;24:895–913.CrossRefPubMed
61.
go back to reference Kao CM, Schneyer RJ, Bocchini JA. Child and adolescent immunizations: selected review of recent US recommendations and literature. Curr Opin Pediatr. 2014;26:383–95.CrossRefPubMed Kao CM, Schneyer RJ, Bocchini JA. Child and adolescent immunizations: selected review of recent US recommendations and literature. Curr Opin Pediatr. 2014;26:383–95.CrossRefPubMed
62.
63.
go back to reference Buttery JP, Madin S, Crawford NW, et al. Mass psychogenic response to human papillomavirus vaccination. MJA. 2008;189(5):261–2.PubMed Buttery JP, Madin S, Crawford NW, et al. Mass psychogenic response to human papillomavirus vaccination. MJA. 2008;189(5):261–2.PubMed
64.
go back to reference Donegan K, Beau-Lejdstrom R, King B, Seabroke S, Thomson A, Bryan P. Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK. Vaccine. 2013;31:4961–7.CrossRefPubMed Donegan K, Beau-Lejdstrom R, King B, Seabroke S, Thomson A, Bryan P. Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK. Vaccine. 2013;31:4961–7.CrossRefPubMed
65.
go back to reference Agmon-Levin N, Hughes GVR, Shoenfeld Y. The spectrum of ASIA: autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants. Lupus. 2012;21:118–20.CrossRefPubMed Agmon-Levin N, Hughes GVR, Shoenfeld Y. The spectrum of ASIA: autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants. Lupus. 2012;21:118–20.CrossRefPubMed
66.
go back to reference Committee to Review Adverse Effects of Vaccines, Institute of Medicine of the National Academies. Summary. In: Adverse effects of vaccine, evidence and causality. Washington, DC: National Academy Press; 2012. p. 1–25. Committee to Review Adverse Effects of Vaccines, Institute of Medicine of the National Academies. Summary. In: Adverse effects of vaccine, evidence and causality. Washington, DC: National Academy Press; 2012. p. 1–25.
Metadata
Title
A sudden onset of a pseudo-neurological syndrome after HPV-16/18 AS04-adjuvated vaccine: might it be an autoimmune/inflammatory syndrome induced by adjuvants (ASIA) presenting as a somatoform disorder?
Authors
Dimitri Poddighe
Lucia Castelli
Gian Luigi Marseglia
Paola Bruni
Publication date
01-12-2014
Publisher
Springer US
Published in
Immunologic Research / Issue 2-3/2014
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-014-8575-3

Other articles of this Issue 2-3/2014

Immunologic Research 2-3/2014 Go to the issue